drugset / Trial / NCT04335526
A Clinical Study to Assess the Effect of Change of Bile Acid on the PD and Safety of Metformin and Microbiome Profiles
Non-randomizedCrossoverOpen-labelBasic science
Summary
This clinical trial is intended to evaluate the effect of change of bile acid pool with cholestyramine on the pharmacodynamics and safety of metformin and intestinal microbiome profiles in healthy volunteers
Timeline
- Start
- 2020-05-01
- Primary completion
- 2020-07-30
- Completion
- 2020-10-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cholestyramine | Other / unclassified | — | — |
Indications
No indication recorded.